These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9419351)
1. Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas. Amoroso SR; Huang N; Roberts AB; Potter M; Letterio JJ Proc Natl Acad Sci U S A; 1998 Jan; 95(1):189-94. PubMed ID: 9419351 [TBL] [Abstract][Full Text] [Related]
2. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes. Berg DJ; Lynch RG J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699 [TBL] [Abstract][Full Text] [Related]
3. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y; Kyprianou N Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Song K; Cornelius SC; Danielpour D Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605 [TBL] [Abstract][Full Text] [Related]
5. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity. Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924 [TBL] [Abstract][Full Text] [Related]
6. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168 [TBL] [Abstract][Full Text] [Related]
7. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
8. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation. Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice. Hilbert DM; Pumphrey JG; Troppmair J; Rapp UR; Rudikoff S Oncogene; 1993 Jul; 8(7):1993-2000. PubMed ID: 7685514 [TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid. De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657 [TBL] [Abstract][Full Text] [Related]
11. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca. Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979 [TBL] [Abstract][Full Text] [Related]
12. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393 [TBL] [Abstract][Full Text] [Related]
13. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation. McNeil N; Kim JS; Ried T; Janz S Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044 [TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100 [TBL] [Abstract][Full Text] [Related]
15. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Kumar A; Rogers T; Maizel A; Sharma S J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Diaz-Chavez J; Hernandez-Pando R; Lambert PF; Gariglio P Mol Cancer; 2008 Jan; 7():3. PubMed ID: 18184435 [TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Wiener F; Coleman A; Mock BA; Potter M Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005 [TBL] [Abstract][Full Text] [Related]